Central and peripheral expression and distribution of NUCB2/nesfatin-1

Current Pharmaceutical Design

Volumn 19, Issue 39, 2013, Pages 6935-6940

  Goebel Stengel, Miriam ^a   Wang, Lixin ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Homeostasis; Hypothalamus; Plasma

Indexed keywords

ALPHA INTERMEDIN; AMPHETAMINE; COCAINE; CORTICOTROPIN RELEASING FACTOR; GHRELIN; GLUCAGON; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; MELANIN CONCENTRATING HORMONE; NESFATIN 1; NEUROPEPTIDE Y; OXYTOCIN; PANCREAS POLYPEPTIDE; POLYPEPTIDE; PROOPIOMELANOCORTIN; SEROTONIN; SOMATOSTATIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; UROCORTIN I; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ANTIBODY LABELING; ARCUATE NUCLEUS; ARTICLE; CARDIOVASCULAR FUNCTION; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID; CONFOCAL MICROSCOPY; DORSAL RAPHE NUCLEUS; EDINGER WESTPHAL NUCLEUS; ENTEROENDOCRINE CELL; FOOD INTAKE; GIGANTOCELLULAR RETICULAR NUCLEUS; HYPOGLOSSAL NUCLEUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL GENICULATE BODY; LATERAL HYPOTHALAMUS; LOCUS CERULEUS; MEDIAL PREOPTIC AREA; NERVE FIBER TRANSPORT; NEUROENDOCRINE SYSTEM; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEUS ACCUMBENS; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAPHE MAGNUS NUCLEUS; RAPHE NUCLEUS; STOMACH MUCOSA; SUPRAOPTIC NUCLEUS; THALAMUS PARAFASCICULAR NUCLEUS; WESTERN BLOTTING;

ANIMALS; BRAIN; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; HUMANS; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS;

EID: 84889028625     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281939131127124814     Document Type: Article

References (50)

1. Oh I, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443(7112): 709-12.
2. Fort P, Salvert D, Hanriot L, et al. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 2008; 155(1): 174-81.
3. Brailoiu GC, Dun SL, Brailoiu E, et al. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007; 148(10): 5088-94.
4. Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008; 156(3): 563-79.
5. Goebel M, Stengel A, Wang L, Lambrecht NW, Taché Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett 2009; 452(3): 241-6.
6. Goebel-Stengel M, Wang L, Stengel A, Tache Y. Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res 2011; 1396: 20-34.
7. Stengel A, Goebel M, Yakubov I, et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009; 150(1): 232-8.
8. Stengel A, Goebel-Stengel M, Jawien J, Kobelt P, Taché Y, Lambrecht NW. Lipopolysaccharide increases gastric and circulating NUCB2/nesfatin-1 concentrations in rats. Peptides 2011; 32(9): 1942-7.
9. Zhang AQ, Li XL, Jiang CY, et al. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010; 16(14): 1735-41.
10. Deniz R, Gurates B, Aydin S, et al. Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine 2012; 42(3): 694-9.
11. Gunay H, Tutuncu R, Aydin S, Dag E, Abasli D. Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder. Psychoneuroendocrinology 2012; 37(12): 1949-53.
12. Chaolu H, Asakawa A, Ushikai M, et al. Effect of exercise and high-fat diet on plasma adiponectin and nesfatin levels in mice. Exp Ther Med 2011; 2(2): 369-73.
13. Ari M, Ozturk OH, Bez Y, Oktar S, Erduran D. High plasma nesfatin-1 level in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35(2): 497-500.
14. Ogiso K, Asakawa A, Amitani H, et al. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011; 32(1): 150-3.
15. Kohno D, Nakata M, Maejima Y, et al. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008; 149(3): 1295-301.
16. Bloem B, Xu L, Morava E, et al. Sex-specific differences in the dynamics of cocaine-and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology 2012; 62(1): 297-303.
17. Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 2011; 96(4): E669-E673.
18. Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002; 87(2): 251-8.
19. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 2004; 46(3): 295-309.
20. Goto Y, Grace AA. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci 2008; 31(11): 552-8.
21. Sheehan TP, Chambers RA, Russell DS. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 2004; 46(1): 71-117.
22. Joels M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci 2009; 10(6): 459-66.
23. Okere B, Xu L, Roubos EW, Sonetti D, Kozicz T. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine-and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res 2010; 1317: 92-9.
24. Franklin KBJ, Paxinos G. The Mouse Brain in Sterostaxic Coordinates. San Diego: Academic Press, Inc.; 1997.
25. Hahn JD. Comparison of melanin-concentrating hormone and hypocretin/orexin peptide expression patterns in a current parceling scheme of the lateral hypothalamic zone. Neurosci Lett 2010; 468(1): 12-7.
26. Inhoff T, Stengel A, Peter L, et al. Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides 2010; 31(2): 257-62.
27. Xu L, Bloem B, Gaszner B, Roubos EW, Kozicz T. Sex-specific effects of fasting on urocortin 1, cocaine-and amphetamineregulated transcript peptide and nesfatin-1 expression in the rat Edinger-Westphal nucleus. Neuroscience 2009; 162(4): 1141-9.
28. Kerbel B, Unniappan S. Nesfatin-1 suppresses energy intake, colocalises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish. J Neuroendocrinol 2012; 24(2): 366-77.
29. Li Z, Xu G, Li Y, Zhao J, Mulholland MW, Zhang W. mTORdependent modulation of gastric nesfatin-1/NUCB2. Cell Physiol Biochem 2012; 29(3-4): 493-500.
30. Foo KS, Brauner H, Ostenson CG, Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 2010; 204(3): 255-63.
31. Gonkowski S, Rychlik A, Nowicki M, Nieradka R, Bulc M, Calka J. A population of nesfatin 1-like immunoreactive (LI) cells in the mucosal layer of the canine digestive tract. Res Vet Sci 2012; 93(3): 1119-21.
32. Garcia-Galiano D, Navarro VM, Gaytan F, Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol 2010; 45(5): 281-90.
33. Garcia-Galiano D, Pineda R, Ilhan T, et al. Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis. Endocrinology 2012; 153(4): 1959-71.
34. Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depotspecific adipokine with increased levels in obesity. Endocrinology 2010; 151(7): 3169-80.
35. Chen CY, Lee WJ, Chong K, Lee SD, Liao YD. Impact of intracerebroventricular obestatin on plasma acyl ghrelin, des-acyl ghrelin and nesfatin-1 levels, and on gastric emptying in rats. Mol Med Report 2012; 6(1): 191-6.
36. Zhang Z, Li L, Yang M, Liu H, Boden G, Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2012; 120(2): 91-5.
37. Ghanbari-Niaki A, Kraemer RR, Soltani R. Plasma nesfatin-1 and glucoregulatory hormone responses to two different anaerobic exercise sessions. Eur J Appl Physiol 2010; 110(4): 863-8.
38. Tsuchiya T, Shimizu H, Yamada M, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in nonobese males. Clin Endocrinol (Oxf) 2010; 73(4): 484-90.
39. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159(1-3): 72-7.
40. Morel-Huaux VM, Pypaert M, Wouters S, et al. The calciumbinding protein p54/NEFA is a novel luminal resident of medial Golgi cisternae that traffics independently of mannosidase II. Eur J Cell Biol 2002; 81(2): 87-100.
41. Taniguchi N, Taniura H, Niinobe M, et al. The postmitotic growth suppressor necdin interacts with a calcium-binding protein (NEFA) in neuronal cytoplasm. J Biol Chem 2000; 275(41): 31674-81.
42. Bustos G, Abarca J, Campusano J, Bustos V, Noriega V, Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Brain Res Rev 2004; 47(1-3): 126-44.
43. Landgraf R, Neumann ID. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 2004; 25(3-4): 150-76.
44. Karabinos A, Bhattacharya D, Kratzin HD, Hilschmann N. Origin of the NEFA and Nuc signal sequences. J Mol Evol 1998; 46(3): 327-33.
45. Valencia CA, Cotten SW, Duan J, Liu R. Modulation of nucleobindin-1 and nucleobindin-2 by caspases. FEBS Lett 2008; 582(2): 286-90.
46. Stengel A, Goebel M, Wang L, Taché Y. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides 2010; 31(2): 263-70.
47. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD. Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 2009; 6: 27.
48. Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114-24.
49. Konczol K, Bodnar I, Zelena D, et al. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int 2010; 57(3): 189-97.
50. Yoshida N, Maejima Y, Sedbazar U, et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamicpituitary-adrenal axis. Aging (Albany NY) 2010; 2(11): 775-84.